Our R&D strategy is a blueprint for our success in the years to come. It guides how we plan to advance innovative therapies for the benefit of patients and physicians. It prioritizes the targets and technologies that will be most promising, and identifies ways to maximize productivity.
The Strategic growth of our core Biomedical Research & Market Implementation programs will achieve a critical mass that fosters interactions & applications applied to life sciences as we seek innovation through synergies and new collaborations between medical science faculties.
The New Architecture of Biomedical Research - As the economics of R&D evolve, private research institutes become increasingly crucial to health care’s changing value chain. Biotech has changed the way biomedical discovery is financed.